Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
NORTH SOUND CAPITAL LLC et al v. MERCK & CO., INC. et al
Case Number:
3:13-cv-07240
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
January 08, 2016
3rd Circ. To Mull Tolling Standard In Merck Investor Row
In a win for Merck, the Third Circuit has said it will weigh questions about the tolling standard established in a 1974 U.S. Supreme Court decision that led a New Jersey federal judge to preserve several fund investors' misrepresentation claims over the drugmaker's anti-cholesterol drug Vytorin.
-
August 27, 2015
Merck Can't Dodge Fraud Case Over Vytorin Trials
Merck & Co Inc. on Wednesday lost its bid to dismiss separate complaints of four institutional funds claiming it misrepresented results of a clinical trial of its anti-cholesterol drug Vytorin, when a New Jersey federal court said statutes of repose have been tolled and the accusations are sufficient to go forward.
-
February 02, 2015
Merck Says Investor Suits Over Vytorin Study Filed Too Late
Merck & Co. Inc. asked a New Jersey federal judge to dismiss four complaints brought by North Sound Capital LLC and three other institutional funds alleging Merck and a subsidiary misrepresented a crucial clinical study for their anti-cholesterol agent Vytorin, saying the suits were brought too late in a filing made public Friday.
-
December 04, 2013
Merck Sued For Securities Fraud Over Cholesterol Drug Trial
North Sound Capital LLC and two other institutional funds have sued Merck & Co. Inc. and its subsidiary for allegedly misrepresenting a crucial clinical study for its anti-cholesterol agents Zetia and Vytorin, according to court documents made public in New Jersey federal court on Wednesday.